What happened in optometry this week: February 5-February 9
Catch up on what happened in optometry during the week of February 5-February 9.
Catch up with what Optometry Times shared this week:
FDA accepts IND for OK-101 for neuropathic corneal pain
By Emily Kaiser Maharjan, Assistant Managing Editor
OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.
UC optometrists strike over “bad-faith” bargaining practices, protest low salaries
By Jordana Joy, Associate Editor
Members of the University Professional and Technical Employees CWA Local 9119 drew picket lines on February 6 and 7 to protest unfair labor and bargaining practices upheld by University of California.
Gaps in vision screening for school-aged children uncovered in study
By Lynda Charters
A new study found that only a little over half of school-aged children participants underwent vision screening within the past two years, highlighting gaps in eye care access.
Diagnosing and treating Demodex blepharitis
By Amy Nau, OD, Dipl CCLRT; Lynda Charters
Everything, no matter how minute, has a purpose and so that must also be the case for the pesky Demodex mite, the infective parasites that lie between or on the eyelashes in highly sebaceous areas. Some researchers think these parasites may help control bacterial populations through their acidic secretions. However, their waste can cause inflammation and hypersensitivity reactions in affected individuals.
ALSTAR study identifies potential functional biomarker for early, intermediate AMD
By Lynda Charters
The study further defined the relationship between delayed rod-mediated dark adaptation and the status of outer retinal bands on optical coherence tomography.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
